ABCG2 and acute myeloid leukemia: The Q141K polymorphism of the ABCG2 protein is related to poor outcome in adults with acute myeloid leukemia treated with idarubicin‐based chemotherapy, and Q141K‐ABCG2 is the most common variant among Caucasians.